Unsay buot ipasabot sa “Klaro”?
Ang mananap wala magdala sa mutation. Dili kini makapalambo sa sakit ug dili kini ipasa.
Discover the importance of the DNA test for Gangliosidosis Type 1 (GM1) in Shiba Inu dogs, a critical genetic screening to ensure your pet’s health. GM1 gangliosidosis is a rare but severe inherited disorder affecting the nervous system, leading to progressive neurological decline. Early DNA testing helps breeders and owners identify carriers and affected dogs, preventing the spread of this debilitating condition. By using a reliable GM1 DNA test, you can make informed breeding decisions and protect future generations of Shiba Inu. Ensure your dog’s well-being with accurate genetic screening for Gangliosidosis Type 1 today. Prioritize health and longevity with this essential DNA test for Shiba Inu.
The DNA test for Gangliosidosis Type 1 (GM1) in Shiba Inu dogs helps identify carriers and affected individuals of this genetic disorder. GM1 gangliosidosis is a rare, inherited lysosomal storage disease that causes progressive neurological decline. Early detection through genetic testing allows breeders to make informed decisions to reduce the risk of passing the condition to offspring. This test is crucial for maintaining the health and longevity of the Shiba Inu breed. Responsible breeding practices rely on such DNA tests to prevent the spread of GM1 in the population.
Kini nga pagsulay sa DNA gilakip sugod sa among pakete Basic — ug kabahin usab sa mga pakete Basic, Standard, Advanced, Complete.
Tan-awa ang DNA Test Packs →Gangliosidosis Type 1, commonly referred to as GM1, is a genetic disorder that affects the metabolism of certain lipids, specifically gangliosides, in the brain and nervous system of dogs. This condition is particularly noted in the Shiba Inu breed. GM1 is caused by a deficiency in the enzyme beta-galactosidase, which leads to the accumulation of gangliosides in the cells, resulting in neurological dysfunction and a range of clinical symptoms.
The symptoms of Gangliosidosis Type 1 typically manifest between the ages of three to six months. Affected dogs may exhibit a variety of neurological signs, including but not limited to, ataxia (loss of coordination), tremors, seizures, and a decline in cognitive functions. As the disease progresses, dogs may experience muscle weakness, difficulty walking, and a general decline in their quality of life. In severe cases, GM1 can lead to premature death, often occurring within the first few years of life.
Diagnosis of Gangliosidosis Type 1 is primarily achieved through genetic testing that identifies mutations in the gene responsible for producing the beta-galactosidase enzyme. While clinical signs can suggest the presence of GM1, definitive diagnosis through a DNA test is crucial for confirming the disorder. Early detection allows for better management of the dog's health and can guide owners in making informed decisions about their pet's care.
Currently, there is no cure for Gangliosidosis Type 1, and treatment focuses on managing the symptoms and improving the quality of life for affected dogs. Supportive care may include physical therapy, pain management, and nutritional support. Regular veterinary check-ups are essential to monitor the progression of the disease and to address any arising complications.
Genetic testing for GM1 is critical for breeders and dog owners. By identifying carriers of the disease, responsible breeding practices can be implemented to reduce the incidence of GM1 in future generations. Awareness and understanding of this condition are vital in promoting the health and longevity of the Shiba Inu breed.
Ang mananap wala magdala sa mutation. Dili kini makapalambo sa sakit ug dili kini ipasa.
Dili. Ang mananap sa kasagaran himsog apan makapasa sa mutation ngadto niini kaliwat.
Nagdala kini og duha ka mutated nga kopya. Ang mga klinikal nga timailhan gilauman depende sa ang sakit. Kinahanglan nga dili kini ipanganak.
Ang ubang mga sakit nalangkit sa sekso, busa ang ilang ekspresyon magkalahi depende sa sekso sa hayop.
This DNA test detects the mutation associated with Gangliosidosis Type 1 In Shiba Inu (GM1-SI) in order to identify clear, carrier, or at-risk animals.
Ang pagsulay sa DNA makatabang sa mga breeder sa pagplano sa mas luwas nga mga pagsanay ug pagpakunhod sa risgo sa pagpasa sa mutation ngadto sa mga anak.
Ang inheritance mode nga gitaho alang niini nga pagsulay mao ang Autosomal Recessive.
This test analyses the mutation GLB1 c.1649delC.
Dili kinahanglan. Ang interpretasyon nagdepende sa sumbanan sa kabilin ug sa resulta nga genotype.
Yamato O, Endoh D, Kobayashi A, Masuoka Y, Yonemura M, Hatakeyama A, Satoh H, Tajima M, Yamasaki M, Maede Y. A novel mutation in the gene for canine acid beta-galactosidase that causes GM1-gangliosidosis in Shiba dogs. J Inherit Metab Dis. 2002 Oct;25(6):525-6. doi: 10.1023/a:1021280007739.
Ang imong pribasiya, imong gipili
Gigamit namo ang importanteng cookies sa pagpadagan sa website. Ang opsyonal nga cookies (sama sa mga embedded content providers) gi-disable pinaagi sa default ug mahimo lamang kung mouyon ka. Mahimo nimong usbon ang imong pagpili bisan kanus-a gamit ang buton nga "Cookies".
Gikinahanglan alang sa kinauyokan nga mga bahin ug seguridad. Kanunay nga gipalihok.
Gipaayo ang mga bahin sama sa pag-save sa gusto o dili pag-advertise nga mga embed.
Nagtabang kanamo nga masabtan ang paggamit sa site. Gi-disable pinaagi sa default.
Advertising/tracking sa tibuok nga mga site (pipila ka video/maps embeds). Gi-disable pinaagi sa default.